Intrapleural Immunotherapy: An Update on Emerging Treatment Strategies for Pleural Malignancy
ConclusionIntrapleural immunotherapies for pleural malignancy have demonstrated promise with regards to generating durable tumor ‐specific immune responses with possible clinical benefits which merit further investigation as part of multimodal chemo‐ and immunotherapeutic regimens.This article is protected by copyright. All rights reserved.
Source: The Clinical Respiratory Journal - Category: Respiratory Medicine Authors: Vivek Murthy,
Daniel Katzman,
Daniel H. Sterman Tags: Series on Pleural Diseases Source Type: research
More News: Asbestosis | Cancer & Oncology | Clinical Trials | Conferences | Immunotherapy | Mesothelioma | Respiratory Medicine | Study